Nutex Health NUTX
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 65th percentile, 5-year average 4.6x
#360 of 2993 stocks by PE (1 = cheapest)
Around its usual level · 48th percentile, 5-year average 5.5x
#3607 of 5328 stocks by PB (1 = cheapest)
Above its usual level · 71st percentile, 5-year average 1.8x
#2166 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.74 | – | 5.46 | 48% (cheaper than usual) | #3607 of 5328 (1 = cheapest) |
| PE | 7.51 | 6.27 | 4.64 | 65% (pricier than usual) | #360 of 2993 (1 = cheapest) |
| PS | 1.50 | 1.27 | 1.81 | 71% (pricier than usual) | #2166 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on NUTX.
Sign in to join the discussion.